Please Wait.....
Report
Renal Biomarkers: Technologies and Global Markets
Market Research Report I 2022-12-16 I 93 Pages I BCC Research
Description
Report Scope:
This report incorporates an in-depth analysis of the renal biomarker market, including market estimations and trends through 2021. Major players, competitive intelligence, innovative technologies, market dynamics and regional opportunities are discussed in detail. The report examines recent developments and product portfolios of major players. The patent analysis focuses on technological trends in recent years in regions such as the U.S., Europe, and Japan. The report presents a market analysis and estimates the CAGR for renal biomarkers.
The scope of the report extends only to renal biomarker consumables and not devices used to study renal biomarkers. All types of renal biomarkers have been considered in research, clinical trials and for diagnostic purposes.
This report segments the global market by these geographic regions: North America, Europe, Asia-Pacific, and the Rest of the World (RoW) region. For market estimates, data is provided for 2021 as the base year, 2022 and forecast through year-end 2027.
Report Includes:
- 41 data tables and 24 additional tables
- A detailed overview and up-to-date analysis of the global markets for renal biomarkers
- Analyses of the global market trends, with market revenue data for 2019-2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
- Estimation of the actual market size and revenue forecast for renal biomarkers market, and corresponding market share analysis by assay type, application, end user, and region
- Updated information on market drivers and opportunities for renal biomarkers, key shifts, regulations and industry specific challenges, and other demographic factors that will shape the market demand over the coming years (2022-2027)
- Identification of the companies best positioned to meet the demand owing to their proprietary technologies, product launches, mergers and acquisitions, and other market strategic advantages
- Review of recent industry structure for biomarkers, R&D activities, and analysis of the competitive landscape based on recent developments and segmental revenues
- Patent activity and review of patent grants for biomarkers and related technologies
- Descriptive company profiles of the market leading players, including BioMerieux, Gentian Diagnostic, Proteomics International, Thermo Fisher Scientific, SphingoTec, and BioPorto
Executive Summary
Summary:
The global market for renal biomarkers reached $REDACTED billion in 2021. The market is expected to grow at acompound annual growth rate (CAGR) of REDACTED% to reach $REDACTED billion during the forecast period.
The renal biomarker market is growing at a steady pace due the increasing prevalence and incidence of the two major kidney diseases: acute kidney injury (AKI) and chronic kidney disease (CKD). These diseases increase hospitalization time, leading to higher costs and morbidity. Early identification of such diseases leads to better treatment, which is possible through biomarkers.
COVID-19 has had a huge impact in increasing the incidence of kidney diseases. Long-term COVID patients have a higher incidence of AKI or CKD. The prevalence of lifestyle diseases such as diabetes and hypertension is also rising. These are closely associated with kidney disorders and malfunction. These diseases are currently the 16th leading cause of death but are expected to be fifth leading by 2030.
The traditional biomarkers used for detecting AKI and CKD have many disadvantages compared to new and novel biomarkers. New biomarkers are being studied and discovered, as there is a gap for an ideal renal biomarker. There is no single renal tumor biomarker that can be pursued by the industry.
Table of Contents
Chapter 1 Introduction
1.1 Study Goals and Objectives
1.2 Reasons for Doing this Study
1.3 What's New in this Report
1.4 Scope of Report
1.5 Information Sources
1.6 Methodology
1.7 Geographic Breakdown
1.8 Analyst's Credentials
1.9 BCC Custom Research
1.10 Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Market Overview
3.1 Introduction
3.1.1 Kidneys
3.1.2 Renal Biomarkers
3.1.3 Definition
3.2 Market Dynamics
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunities
3.3 Regulatory Process for Biomarkers
3.3.1 European Medicines Agency
3.3.2 Biomarkers Qualified by the FDA
Chapter 4 Impact of COVID-19 Pandemic
4.1 Impact of COVID-19 on Renal Biomarker Market
4.1.1 Increased Incidence of AKI
4.1.2 Other Diseases
4.2 Chronic Dialysis Patients
4.2.1 Kidney Transplant Recipients
Chapter 5 Global Renal Biomarker Market by Type
5.1 Overview
5.2 Filtered Renal Biomarkers (Impaired Tubular Reabsorption)
5.2.1 Albumin
5.2.2 Cystatin C
5.2.3 Beta-2 Microglobulin
5.3 Upregulated Biomarkers
5.3.1 KIM-1 Kidney Injury Molecule
5.3.2 Neutrophil Gelatinase Associated Lipocalin
5.3.3 Clusterin
5.3.4 Interleukin-18
5.3.5 Netrin-1
5.4 Preformed
5.4.1 Alkaline Phosphatase
5.4.2 Gamma-Glutamyl Transpeptidase
5.4.3 Glutathione S-Transferase
5.4.4 N-acetyl-?-D Glucosaminidase
5.4.5 Liver-Type Fatty Acid-Binding Protein
5.4.6 Tissue Inhibitor of Metalloprotease-2 and Insulin-Like Growth Factor-binding Protein 7
5.5 Other Biomarkers
5.5.1 Blood Urea Nitrogen
5.5.2 Serum Creatinine
5.5.3 Downregulated
Chapter 6 Global Market for Renal Biomarkers by Region
6.1 North America
6.1.1 United States
6.1.2 Canada
6.2 Europe
6.2.1 Germany
6.2.2 Italy
6.2.3 France
6.2.4 Spain
6.2.5 United Kingdom
6.2.6 Rest of Europe
6.3 Asia-Pacific
6.3.1 Australia
6.3.2 Japan
6.3.3 China
6.3.4 Rest of Asia
6.4 Rest of the World
Chapter 7 Renal Biomarker Market by End User
7.1 Hospitals
7.2 Research Centers
7.3 Other End Users
Chapter 8 Renal Biomarker Market by Technique
8.1 Overview
8.2 Enzyme Linked Immunosorbent Assay
8.3 Particle-Enhanced Turbidimetric Immunoassays
8.4 Colorimetric Assays
8.5 Chemiluminescent Enzyme Immunoassays
8.6 Other Detection Methods
Chapter 9 Competitive Landscape
Chapter 10 Company Profiles
ABBOTT LABORATORIES
BECKMAN COULTER INC.
BIOMERIEUX
BIOPORTO A/S
BIO-RAD
ENZO BIOCHEM INC.
GENTIAN DIAGNOSTIC AB
HYTEST LTD.
NEPHROSANT
Nexelis
PROTEOMICS INTERNATIONAL LABORATORIES LTD.
RANDOX LABORATORIES LTD.
ROCHE (F. HOFFMANN-LA ROCHE AG)
SPHINGOTEC
THERMO FISHER SCIENTIFIC
Chapter 11 Patent Review
Chapter 12 Clinical Trial Analysis
List of Tables
Summary Table : Global Market for Renal Biomarkers, by Segment, Through 2027
Table 1 : Applications for Biomarkers, with Examples
Table 2 : Changes in Aging Kidneys
Table 3 : Qualified Biomarkers of EMA SAWP/CHMP, as of March 30, 2020
Table 4 : Stages in the FDA Biomarker Qualification Program
Table 5 : Qualified Biomarkers for FDA CDER BQP, as of Feb. 19, 2020
Table 6 : Cases of COVID-19 and Related Deaths, by Country, as of October 2022
Table 7 : Effects of COVID-19 on Kidney Disease Patients
Table 8 : Properties of KIM-1
Table 9 : Global Market for Renal Biomarkers, by Region, Through 2027
Table 10 : AKI in Developed and Developing Countries
Table 11 : North American Market for Renal Biomarkers, by Country, Through 2027
Table 12 : North American Market for Renal Biomarkers, by Type, Through 2027
Table 13 : U.S. Market for Renal Biomarkers, by Type, Through 2027
Table 14 : Canadian Market for Renal Biomarkers, by Type, Through 2027
Table 15 : European Kidney Health Alliance Recommendations
Table 16 : European Market for Renal Biomarkers, by Region, Through 2027
Table 17 : European Market for Renal Biomarkers, by Type, Through 2027
Table 18 : German Market for Renal Biomarkers, by Type, Through 2027
Table 19 : Italian Market for Renal Biomarkers, by Type, Through 2027
Table 20 : French Market for Renal Biomarkers, by Type, Through 2027
Table 21 : Spanish Market for Renal Biomarkers, by Type, Through 2027
Table 22 : U.K. Market for Renal Biomarkers, by Type, Through 2027
Table 23 : Rest of Europe Market for Renal Biomarkers, by Type, Through 2027
Table 24 : Asia-Pacific Market for Renal Biomarkers, by Country, Through 2027
Table 25 : Asia-Pacific Market for Renal Biomarkers, by Type, Through 2027
Table 26 : Australian Market for Renal Biomarkers, by Type, Through 2027
Table 27 : Japanese Market for Renal Biomarkers, by Type, Through 2027
Table 28 : Chinese Market for Renal Biomarkers, by Type, Through 2027
Table 29 : Rest of Asia Market for Renal Biomarkers, by Type, Through 2027
Table 30 : RoW Market for Renal Biomarkers, by Type, Through 2027
Table 31 : Global Market for Renal Biomarkers, by End User, Through 2027
Table 32 : Global Market for Renal Biomarkers, by Technique, Through 2027
Table 33 : Methods for Detection of Renal Biomarkers
Table 34 : Company Developments, 2019-2022
Table 35 : Abbott Laboratories: Renal Biomarker Portfolio
Table 36 : Abbott Laboratories: Revenue and R&D Expenses, 2019 to 2021
Table 37 : Abbott Laboratories: Revenue, by Segment
Table 38 : BioMerieux: Revenue and R&D Expenditure, 2019-2021
Table 39 : BioMerieux: Revenue of Immunoassay Segment, 2019-2021
Table 40 : BioMerieux: Recent Developments, 2019-2022
Table 41 : Bioporto: Revenue and R&D Expense, 2019-2021
Table 42 : Bioporto: NGAL Revenue, 2019-2021
Table 43 : Bioporto: Recent Developments, 2019-2022
Table 44 : Bio-Rad: Kidney Toxicity Assay Portfolio
Table 45 : Bio-Rad: Revenue and R&D Expense, 2019-2021
Table 46 : Enzo Biochem: Revenue and R&D Expenses, 2019-2021
Table 47 : Enzo Biochem: Revenue, by Segment, 2019-2021
Table 48 : Enzo Biochem: Revenue, by Region, 2019 to 2021
Table 49 : Gentian Diagnostic: Revenue, by Region, 2019-2021
Table 50 : Gentian Diagnostic: Recent Developments, 2019-2022
Table 51 : Nexelis: Recent Developments, 2019-2022
Table 52 : Nexelis: Renal Biomarker Portfolio
Table 53 : Proteomics International: Revenue, 2019-2022
Table 54 : Proteomics: Recent Developments, 2019-2022
Table 55 : Roche: Revenue and R&D Expenses, 2019-2021
Table 56 : Roche: Revenue, by Segment, 2019-2021
Table 57 : Roche: Revenue, by Diagnostic Segment, 2019-2021
Table 58 : Roche: Revenue, by Region, 2019 to 2022
Table 59 : Sphingotec: Recent Developments, 2019-2022
Table 60 : Thermo Fisher Scientific: Revenue and R&D Expenses, 2019-2021
Table 61 : Thermo Fisher Scientific: Revenue, by Segment, 2019-2021
Table 62 : Thermo Fisher Scientific: Recent Developments, 2019-2022
Table 63 : Precision Medicine Patent Criteria in U.S. and Europe
Table 64 : List of Renal Biomarker Patents
List of Figures
Summary Figure : Global Market for Renal Biomarkers, by Type, 2019-2027
Figure 1 : Applications for Biomarkers
Figure 2 : Timeline for Renal Biomarkers
Figure 3 : Initial Timeline of EMA Biomarker Qualification
Figure 4 : Flowchart of EMA Biomarker Qualification Process
Figure 5 : Steps in EMA Biomarker Qualification
Figure 6 : Steps in Biomarker Quantification
Figure 7 : Pathways for Excretion of IGFBP7 and TIMP-2
Figure 8 : Percentage of CKD Patients, by Age, in U.S.
Figure 9 : Number of Patients Receiving Kidney Dialysis in Canada
Figure 10 : EU Patients Undergoing Kidney Dialysis and Transplants
Figure 11 : Shares of Leading Companies in the Renal Biomarker Market
Figure 12 : Clinical Trials of Renal Biomarkers, by Therapeutic Area, 2019 to October 2022
Figure 13 : Clinical Trials of Renal Biomarkers, by Sponsor
Figure 14 : Clinical Trials of Renal Biomarkers, by Location
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security